Korea Investment Partners

1 stories about Korea Investment Partners
default image

Cell Immunotherapy Company Raises $8 Million

24.09.17|Lilach Baumer
Enlivex Therapeutics Ltd. is a clinical-stage company specializing in autoimmune and inflammatory conditions
ProfilesEngineServlet?at=39&mi=10&pt=18&dpi=1243103233&pai=cTech&dpn=4409&mt=1